Catalyst Wire Dossier Catalyst Wire Dossier

low-dose Ara-C

cytarabine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for low-dose Ara-C, covering 2018-10-09 to 2018-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C [Phase 2]

See pricing